mizoribine has been researched along with Asystole in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Higuchi, T; Horiba, Y; Hoshinaga, K; Naide, Y; Shiroki, R; Yanaoka, M | 1 |
Higuchi, T; Horiba, M; Hoshinaga, K; Izumitani, M; Naide, Y; Shiroki, R; Tsukiashi, Y | 1 |
2 other study(ies) available for mizoribine and Asystole
Article | Year |
---|---|
Quadruple immunotherapy will promise excellent graft survival in cadaveric renal transplants using cardiac arrest donor grafts.
Topics: Adolescent; Adult; Antilymphocyte Serum; Azathioprine; Cadaver; Creatinine; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft Survival; Heart Arrest; Humans; Immunosuppressive Agents; Kidney Transplantation; Methylprednisolone; Middle Aged; Ribonucleosides; Survival Rate; Tissue Donors | 1996 |
Quadruple immunosuppressive therapy with low-dose cyclosporine provides superior kidney transplant outcome using grafts of non-heart-beating uncontrolled cadavers.
Topics: Adolescent; Adult; Aged; Antilymphocyte Serum; Azathioprine; Cadaver; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Heart Arrest; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Postoperative Complications; Retrospective Studies; Ribonucleosides; Survival Rate; Tissue Donors | 1997 |